[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB1196594A - Improvements in and relating to the production of Sebacic Acid - Google Patents

Improvements in and relating to the production of Sebacic Acid

Info

Publication number
GB1196594A
GB1196594A GB5260266A GB5260266A GB1196594A GB 1196594 A GB1196594 A GB 1196594A GB 5260266 A GB5260266 A GB 5260266A GB 5260266 A GB5260266 A GB 5260266A GB 1196594 A GB1196594 A GB 1196594A
Authority
GB
United Kingdom
Prior art keywords
sebacic acid
production
acid
relating
hydrogenation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5260266A
Inventor
Frederick Harold Howell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Geigy Co Ltd
Original Assignee
Geigy Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Co Ltd filed Critical Geigy Co Ltd
Priority to GB5260266A priority Critical patent/GB1196594A/en
Priority to CH1598667A priority patent/CH488646A/en
Priority to BE706983D priority patent/BE706983A/xx
Priority to FR129355A priority patent/FR1545224A/en
Priority to DE19671668157 priority patent/DE1668157A1/en
Publication of GB1196594A publication Critical patent/GB1196594A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/20—Sebacic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1,196,594. Production of sebacic acid. GEIGY (U.K.) Ltd. 23 Nov., 1967 [21 Dec., 1966], No. 52602/66. Heading C2C. Sebacic acid is prepared by hydrogenating 5-ketosebacic acid or 5-hydroxysebacic acid, or an alkali metal salt of either, with molecular hydrogen at a temperature above 200‹ C., in the presence of a hydrogenation catalyst of palladium or platinum. The hydrogenation may be effected in aqueous solution at a superatmospheric pressure for a period of from 4 to 8 hours.
GB5260266A 1966-12-21 1966-12-21 Improvements in and relating to the production of Sebacic Acid Expired GB1196594A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB5260266A GB1196594A (en) 1966-12-21 1966-12-21 Improvements in and relating to the production of Sebacic Acid
CH1598667A CH488646A (en) 1966-12-21 1967-11-16 Process for the production of sebacic acid
BE706983D BE706983A (en) 1966-12-21 1967-11-23
FR129355A FR1545224A (en) 1966-12-21 1967-11-23 Process for preparing sebacic acid
DE19671668157 DE1668157A1 (en) 1966-12-21 1967-11-23 Process for the production of sebacic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5260266A GB1196594A (en) 1966-12-21 1966-12-21 Improvements in and relating to the production of Sebacic Acid

Publications (1)

Publication Number Publication Date
GB1196594A true GB1196594A (en) 1970-07-01

Family

ID=10464554

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5260266A Expired GB1196594A (en) 1966-12-21 1966-12-21 Improvements in and relating to the production of Sebacic Acid

Country Status (4)

Country Link
BE (1) BE706983A (en)
CH (1) CH488646A (en)
DE (1) DE1668157A1 (en)
GB (1) GB1196594A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119221B2 (en) 2003-01-23 2006-10-10 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US10912751B2 (en) 2015-03-13 2021-02-09 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
US11116739B2 (en) 2015-03-16 2021-09-14 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and one or more statins and methods of treating or reducing cardiovascular disease
US11407705B2 (en) 2019-06-21 2022-08-09 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9000041B2 (en) 2003-01-23 2015-04-07 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US10941095B2 (en) 2003-01-23 2021-03-09 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US7119221B2 (en) 2003-01-23 2006-10-10 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US7405226B2 (en) 2003-01-23 2008-07-29 Pfizer Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US7576130B2 (en) 2003-01-23 2009-08-18 Esperion Therapeutics, Inc. Dihydroxyl compounds and compositions for cholesterol management and related uses
US7812199B2 (en) 2003-01-23 2010-10-12 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US7838554B2 (en) 2003-01-23 2010-11-23 Esperion Therapeutics, Inc. Dihydroxyl compounds and compositions for cholesterol management and related uses
US8067466B2 (en) 2003-01-23 2011-11-29 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management
US8153690B2 (en) 2003-01-23 2012-04-10 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management
US8309604B2 (en) 2003-01-23 2012-11-13 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US8497301B2 (en) 2003-01-23 2013-07-30 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US8623915B2 (en) 2003-01-23 2014-01-07 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US7335689B2 (en) 2003-01-23 2008-02-26 Esperion Therapeutics, Inc. Dihydroxyl compounds and compositions for cholesterol management and related uses
US9006290B2 (en) 2003-01-23 2015-04-14 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US9452964B2 (en) 2003-01-23 2016-09-27 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US9624152B2 (en) 2003-01-23 2017-04-18 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US10047028B2 (en) 2003-01-23 2018-08-14 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US10118881B2 (en) 2003-01-23 2018-11-06 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US7335799B2 (en) 2003-01-23 2008-02-26 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US10912751B2 (en) 2015-03-13 2021-02-09 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
US11744816B2 (en) 2015-03-13 2023-09-05 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
US11116739B2 (en) 2015-03-16 2021-09-14 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and one or more statins and methods of treating or reducing cardiovascular disease
US11407705B2 (en) 2019-06-21 2022-08-09 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same
US11613511B2 (en) 2019-06-21 2023-03-28 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same
US11760714B2 (en) 2019-06-21 2023-09-19 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same
US11926584B2 (en) 2019-06-21 2024-03-12 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same
US11987548B2 (en) 2019-06-21 2024-05-21 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same

Also Published As

Publication number Publication date
DE1668157A1 (en) 1971-09-02
CH488646A (en) 1970-04-15
BE706983A (en) 1968-05-24

Similar Documents

Publication Publication Date Title
GB1343289A (en) Catalytic method for hydrogenating nitro-compounds
GB1191113A (en) Production of Saturated Carbonyl Compounds
GB1196594A (en) Improvements in and relating to the production of Sebacic Acid
GB1022480A (en) Production of mannitol and sorbitol
GB1229707A (en)
GB1381837A (en) Process for the manufacture of triacetone-amine
GB1226132A (en)
GB1126169A (en) Process for the conversion of hydrocarbons
GB1244442A (en) Process for the production of saturated alcohols
GB1100748A (en) Process for the manufacture of a terpene derivative
GB1274551A (en) Improvements in a process for the production of triaminobenzene
GB1196596A (en) Preparation of a hydroxysebacic acid
GB1142059A (en) Method for preparing hydroxybenzoic acids
GB1310143A (en) Manufacture of 2-ethylhexanal-1
SE329148B (en)
GB1296448A (en)
GB1129586A (en) A process for the production of mannitol
GB877882A (en) Improvements in the production of bivanillyl
GB1181969A (en) Manufacture of rho-Aminophenol by the Catalytic Hydrogenation of Nitrobenzene
GB1457054A (en) Manufacture of 3-aminobenzoylbenzoic acids
GB1205141A (en) Process for producing monoethylamine
GB1243327A (en) Process for the preparation of piperidine
GB1187419A (en) 02-Acetamidododecanoic Acid and Process for its Production
GB1155538A (en) Process for the Manufacture of beta,beta-Dimethylacrylic Acid
GB1154359A (en) Hydrogenated Moenomycin and process for preparing it

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees